Home Molecular Dx Prenatal/Postnatal Testing

Prenatal/Postnatal Testing

Latest
Prenatal genetic screening based on genomic medical technology increasingly allows for the detection and diagnosis of discreet genetic abnormalities within a clinical setting. [Ernesto del Aguila III
Prenatal/Postnatal Testing

New Single-Cell NIPT Lowers Risks, Improves Accuracy in Proof-of-Concept Study

Prenatal/Postnatal Testing

Rady Children’s, Deloitte Study Delivery of Genomic Samples by Drone

Prenatal/Postnatal Testing

ACMG Launches Evidence-Based Guidelines for Genetic, Genomic Testing

Prenatal/Postnatal Testing

NIPT Startup Cradle Genomics Closes $17.1M Series A Financing

Prenatal/Postnatal Testing

Invitae to Expand NIPS Services with Singular Bio Acquisition

passive smoking concept
Prenatal/Postnatal Testing

Secondhand Smoke Increases Unborn Babies’ Risk of Congenital Heart Defects

BGI Genomics plans to commercialize Natera’s Signatera molecular residual disease (MRD) test in China
Prenatal/Postnatal Testing

BGI Genomics to Commercialize Natera’s Signatera Assay in China

PerkinElmer is partnering with Women & Infants Hospital (WIH) of Rhode Island
Prenatal/Postnatal Testing

PerkinElmer, Hospital Partner on Clinical Trial of Vanadis NIPT Platform

Source:Jill Lehmann Photography/Getty Images
Prenatal/Postnatal Testing

Blood Test Identifies Preterm Birth Risk of Expectant Mothers

Invitae says its acquisitions of CombiMatrix and Goog Start Genetics
Prenatal/Postnatal Testing

Invitae Expands NIPT Footprint with Two Acquisitions

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up